Home Newsletters Intestinal Cell News ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test

0
ProPhase Labs, Inc. announced it has completed its previously announced acquisition of the worldwide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostic screening test and related intellectual property assets from Stella Diagnostics, Inc.
[ProPhase Labs, Inc.]
Press Release
Exit mobile version